As of November 2024, Newron Pharmaceuticals has a market cap of $171.10M. This makes Newron Pharmaceuticals the world's 18284th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $175.31M | 68.08% |
2023 | $104.30M | 219.35% |
2022 | $32.66M | -4.32% |
2021 | $34.14M | -24.65% |
2020 | $45.30M | -66.14% |
2019 | $133.80M | 13.19% |
2018 | $118.21M | -51.64% |
2017 | $244.43M | -42.43% |
2016 | $424.59M | -21.29% |
2015 | $539.43M | -2.29% |
2014 | $552.07M | 55.95% |
2013 | $354.00M | 108.96% |
2012 | $169.41M | 265.45% |
2011 | $46.36M | -61.27% |
2010 | $119.69M | -69.63% |
2009 | $394.03M | 34.53% |
2008 | $292.89M | -72.75% |
2007 | $1.07B | -4.32% |
2006 | $1.12B | - |